Trazodone is an antidepressant that doctors often prescribe off-label for sleep. It ranks among the most prescribed treatments for chronic insomnia, yet the evidence behind that use is thin. The American Academy of Sleep Medicine (AASM) suggests clinicians not use it for sleep onset or sleep maintenance insomnia. The American College of Physicians and the VA/DoD guideline also advise against it. The picture changes for one group: people who have insomnia and depression together. A 2025 meta-analysis found trazodone improved sleep quality in that group. Only a prescriber who knows your health history can decide. This is educational information, not medical advice.
Short answer (40-60 words): Trazodone is an antidepressant prescribed off-label for insomnia. The AASM suggests against using it for chronic insomnia because trial evidence is limited and the one qualifying trial showed small, not clinically meaningful, gains. It may help sleep in people who also have depression. CBT-I remains the first-line treatment.
Why Do So Many Doctors Prescribe It?
Trazodone is FDA-approved for major depression, not insomnia. At low doses, around 25 to 100 mg, it causes sedation. Higher antidepressant doses run from 150 to 600 mg. Many prescribers see trazodone as safer than Z-drugs like Ambien because it is not a controlled substance and carries less dependence worry. A protocol for a large registered trial notes that many providers hesitate to prescribe zolpidem for those reasons, which pushes them toward trazodone.
That popularity runs ahead of the evidence. A 2023 review called trazodone one of the most prescribed treatments for chronic insomnia despite limited data on its efficacy and side effects.
What Do the Guidelines Say?
Three major bodies reached the same conclusion:
- AASM (2017): Suggests clinicians not use trazodone for sleep onset or sleep maintenance insomnia in adults. It issued a weak recommendation against it.
- American College of Physicians (2016): Recommended against trazodone in its insomnia guidance.
- VA/DoD: Advised against it because low-quality efficacy evidence did not outweigh its adverse effects.
The AASM based its call on a single 50 mg trial that met its inclusion criteria. In that trial, trazodone shortened sleep latency by about 10 minutes and wake time after sleep onset by about 8 minutes, and it added about 22 minutes of total sleep time. None of those changes reached clinical significance. Side effects ran higher than placebo: headache in 30 percent versus 19 percent, and somnolence in 23 percent versus 8 percent.
At a Glance: The Evidence on Trazodone
| Source | Finding |
|---|---|
| AASM 2017 guideline | Weak recommendation against use for sleep onset or maintenance insomnia |
| Single 50 mg trial in the guideline | Small gains in sleep, none clinically significant; more headache and somnolence than placebo |
| 2018 Cochrane review (3 RCTs, 370 people) | No difference in sleep efficiency on polysomnography in two low-quality trials |
| 2025 meta-analysis in depression-related insomnia | Significant sleep quality improvement (SMD 0.83) |
| Registered trials | A large trial now compares CBT-I, zolpidem, and trazodone head to head |
Is the Evidence Really That Weak?
It is mixed. Some meta-analyses support trazodone. Pooled data show better subjective sleep quality and fewer night awakenings. A 2024 systematic review reported less time awake after sleep onset and more objectively measured total sleep time. In contrast, one analysis found trazodone did not change how long people felt they slept.
A 2022 meta-analysis of 11 randomized trials with 466 participants found trazodone changed several sleep-stage measures on polysomnography. The authors rated the quality of evidence as low or very low for most outcomes, and they noted that trials mixing in other therapies muddy the results. Quality, not just direction, is the problem.
What About People With Depression and Insomnia?
This group is different. The AASM guideline looked at insomnia on its own and did not assess people who also have depression. A 2025 meta-analysis of 10 randomized trials found trazodone significantly improved sleep quality in patients with depression, with a standardized effect of 0.83, and it also improved depressive symptoms. If you take trazodone for depression and it helps your sleep, that is a different situation than taking it only for insomnia. Your prescriber can tell you which applies.
What Are the Side Effects and Risks?
Common side effects include drowsiness, dizziness, dry mouth, nausea, and blurred vision. Higher doses increase the risk of low blood pressure when you stand up. Drug labels also carry warnings for priapism, a prolonged painful erection that needs emergency care, and for serotonin syndrome when combined with other serotonergic drugs. As an antidepressant, trazodone carries the FDA’s boxed warning about suicidal thoughts, mainly in younger people. Tell your prescriber about every medication and supplement you take, including 5-HTP and St. John’s wort.
How Does It Compare With CBT-I?
CBT-I stays first-line. The AASM gives it a strong recommendation, and a 2025 review found CBT-I alone worked best. Medication added only modest benefit for a few outcomes. If your doctor offers trazodone, ask about CBT-I too. Read our CBT-I guide. If you later want to stop, follow our guide to stopping sleeping pills safely and talk to your prescriber first.
Questions to Ask Your Prescriber
- Am I taking this for insomnia, depression, or both?
- Why trazodone instead of CBT-I, or in addition to it?
- What dose do you suggest, and how long will I take it?
- Which side effects should make me call you right away?
- How does it interact with my other medications and supplements?
- How will we decide to stop, and what is the plan?
Want help preparing for that conversation? If you would like to see how we might be able to help you with this deeper, schedule a free consult here.
What the Research Shows
Major guidelines advise against trazodone for insomnia. The AASM, American College of Physicians, and VA/DoD all recommend against it, citing limited and low-quality evidence.
The one qualifying trial showed small gains and more side effects. At 50 mg, trazodone produced changes in sleep that did not reach clinical significance, while headache and somnolence ran higher than placebo.
Meta-analyses disagree and rate the evidence as weak. Some find better subjective sleep quality and fewer awakenings, but a 2022 meta-analysis graded most outcomes as low or very low certainty.
People with depression may benefit. A 2025 meta-analysis of 10 trials found a significant sleep quality gain in patients with depression, a group the AASM guideline did not assess.
This article is for educational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment.
Want a Free Starting Point?
Join the free sleep course and community: Join the Sleep Nirvana Club
When to Seek Professional Help
- You take trazodone and feel groggy, dizzy, or faint when you stand up
- You have depression, anxiety, or thoughts of self-harm along with poor sleep
- You take other serotonergic drugs or supplements
- You want to stop trazodone after taking it regularly
- Your insomnia has lasted three months or longer
Frequently Asked Questions
Is trazodone good for sleep?
The evidence is limited. The AASM suggests against using it for chronic insomnia, and the one qualifying trial showed small gains that did not reach clinical significance. It may help sleep in people who also have depression.
Why does my doctor prescribe trazodone for insomnia?
Many doctors see it as a safer alternative to Z-drugs because it is not a controlled substance and carries less dependence concern. That popularity has grown faster than the trial evidence for it.
Is trazodone better than Ambien?
A short-term trial found trazodone less effective than zolpidem, and the AASM guideline favors FDA-approved hypnotics over trazodone. Ambien carries its own risks, covered in our Ambien side effects guide.
What are the main side effects of trazodone?
Drowsiness, dizziness, dry mouth, nausea, and blurred vision are common. Labels also warn about priapism, serotonin syndrome with other serotonergic drugs, and suicidal thoughts as part of the antidepressant boxed warning.
Should I try CBT-I instead of trazodone?
Guidelines put CBT-I first for chronic insomnia. It has a strong recommendation from the AASM, and a 2025 review found it worked better than medication alone for most outcomes. Ask your doctor about it before or alongside any drug.
When to Work With a Sleep Consultant
Trazodone is popular, but popularity is not proof. If you want a plan that does not depend on a pill, or help preparing for a medication conversation, we can help.
